Health Products

RIVA-Olanzapine (2015-02-18)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
C1362B. RIVA-Olanzapine 5 mg
Recalling Firm
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
TabletDIN 02337134Olanzapine 5 mg
C1729, C0940C. RIVA-Olanzapine 7.5 mg
Recalling Firm
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
TabletDIN 02337142Olanzapine 7.5 mg
C0938A. RIVA-Olanzapine 2.5 mg
Recalling Firm
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
TabletDIN 02337126Olanzapine 2.5 mg

Introduction

Recalled Products

A. RIVA-Olanzapine 2.5 mg

B. RIVA-Olanzapine 5 mg

C. RIVA-Olanzapine 7.5 mg

Reason

This lot is potentially contaminated with foreign tablets (Ondansetron 8mg).

Depth of distribution

Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime